Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Tempest Minerals Ltd

Country

Ownership: -

Employees: 6

Market Cap: -

Website

Introduction: Tempest Minerals Ltd is engaged in the exploration of precious metals, base metals, and energy metals. The projects include Range Project, Messenger Project, Rocky Hill Project, Warriedar and many more. The firm has one reportable segment, being the exploration of mineral projects in Western Australia. Geographically it operates in Australia, Zimbabwe and Mozambique and derives key revenue from Australia.

Clinical Trials

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Not Applicable

Not yet recruiting

Conditions: Pulmonary Hypertension
Interstitial Lung Disease (ILD)

First Posted Date: 2025-04-04

Last Posted Date: 2025-04-04

Lead Sponsor: Tempus AI

Target Recruit Count: 1000

Registration Number: NCT06911632

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Recruiting

Conditions: Cancer

First Posted Date: 2024-01-16

Last Posted Date: 2025-05-08

Lead Sponsor: Tempus AI

Target Recruit Count: 500

Registration Number: NCT06207032

Locations: 🇺🇸
Alabama Oncology, Birmingham, Alabama, United States
🇺🇸
PIH Health Whittier Hospital & PIH Health Physicians, Whittier, California, United States
🇺🇸
Eastern CT and Hematology and Oncology Associates, Norwich, Connecticut, United States

and more 25 locations

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Recruiting

Conditions: Head and Neck Squamous Cell Carcinoma

First Posted Date: 2023-12-11

Last Posted Date: 2025-07-01

Lead Sponsor: Tempus AI

Target Recruit Count: 500

Registration Number: NCT06163534

Locations: 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
Morehouse, Atlanta, Georgia, United States

and more 15 locations

Addressing Undertreatment and Health Equity in Aortic Stenosis Using an Integrated EHR Platform

Not Applicable

Recruiting

Conditions: Aortic Valve Stenosis
Mitral Regurgitation

First Posted Date: 2023-10-25

Last Posted Date: 2025-05-01

Lead Sponsor: Tempus AI

Target Recruit Count: 2626

Registration Number: NCT06099665

Locations: 🇺🇸
Saint Luke's Health System, Kansas City, Missouri, United States
🇺🇸
OhioHealth, Columbus, Ohio, United States
🇺🇸
Bon Secours Mercy Health - Lima Market, Lima, Ohio, United States

and more 3 locations

Umbrella Study for Analysis of Data Related to Patients With Cancer

Recruiting

Conditions: Cancer

First Posted Date: 2023-08-31

Last Posted Date: 2025-04-13

Lead Sponsor: Tempus AI

Target Recruit Count: 10000

Registration Number: NCT06018753

Locations: 🇺🇸
Cancer Specialists of Northern Florida, Jacksonville, Florida, United States
🇺🇸
Memorial Health Services, Fountain Valley, California, United States
🇺🇸
Hawaii Cancer Care, Honolulu, Hawaii, United States

and more 7 locations

Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease

Not Applicable

Active, not recruiting

Conditions: Atrial Fibrillation
Structural Heart Disease

First Posted Date: 2022-07-01

Last Posted Date: 2024-07-25

Lead Sponsor: Tempus AI

Target Recruit Count: 1000

Registration Number: NCT05442203

Locations: 🇺🇸
Corewell Health, Grand Rapids, Michigan, United States
🇺🇸
TriHealth, Cincinnati, Ohio, United States
🇺🇸
Geisinger Medical Center, Danville, Pennsylvania, United States

Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study

Recruiting

Conditions: Small Cell Lung Cancer

First Posted Date: 2022-02-25

Last Posted Date: 2025-05-06

Lead Sponsor: Tempus AI

Target Recruit Count: 50

Registration Number: NCT05257551

Locations: 🇺🇸
Cancer and Blood Specialty Clinic, Los Alamitos, California, United States
🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸
Illinois Cancer Care, Peoria, Illinois, United States

and more 8 locations

GEMINI-NSCLC: NSCLC Biomarker Study

Recruiting

Conditions: Non-Small Cell Lung Cancer

First Posted Date: 2022-02-11

Last Posted Date: 2025-05-08

Lead Sponsor: Tempus AI

Target Recruit Count: 1200

Registration Number: NCT05236114

Locations: 🇺🇸
Alabama Oncology, Birmingham, Alabama, United States
🇺🇸
Mercy Clinic Oncology - Fort Smith, Fort Smith, Arkansas, United States
🇺🇸
MemorialCare, Fountain Valley, California, United States

and more 54 locations

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Recruiting

Conditions: Colorectal Cancer

First Posted Date: 2022-02-10

Last Posted Date: 2025-05-06

Lead Sponsor: Tempus AI

Target Recruit Count: 300

Registration Number: NCT05234177

Locations: 🇺🇸
Mercy Clinic Oncology - Fort Smith, Fort Smith, Arkansas, United States
🇺🇸
MemorialCare, Fountain Valley, California, United States
🇺🇸
The Center for Cancer and Blood Disorders, Bethesda, Maryland, United States

and more 17 locations

Tempus Priority Study: A Pan-tumor Observational Study

Active, not recruiting

Conditions: Breast Cancer
Ovarian Cancer
Cancer of Head and Neck
Cancer of Gastrointestinal Tract
Cancer of Kidney
Lymphoma
Bladder Cancer
Brain Cancer
Pancreatic Cancer
Fallopian Tube Cancer

First Posted Date: 2022-01-05

Last Posted Date: 2025-05-06

Lead Sponsor: Tempus AI

Target Recruit Count: 1000

Registration Number: NCT05179824

Locations: 🇺🇸
UT Southwestern, Dallas, Texas, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy